CRC Sanjiu is a state-owned enterprise.
Chinese Resources Sanjiu Medicine Co., Ltd (CR Sanjiu) is a large state-controlled pharmaceutical listed company, formerly known as Shenzhen Southern Pharmaceutical Factory. on April 21, 1999, initiated the establishment of the joint-stock company. on March 9, 2000 in the Shenzhen Stock Exchange listing, stock code 000999. Stock code 000999.
The company formally entered the China Resources Group at the end of November 2007.
In February 2010, the company's name was formally changed from "Sanjiu Pharmaceutical Company Limited" to "China Resources Sanjiu Pharmaceutical Company Limited". In February 2010, the company name was officially changed from "Sanjiu Medicine Co.
September 23, 2019, the Ministry of Education and other four departments identified as the first batch of national vocational education teachers enterprise practice base. 2020 April, selected by the State Council State-owned Assets Supervision and Administration Commission of the State Council's "science and technology reform demonstration enterprises" list. 2022 December 14 in the investor interactive platform, said that China Resources Sanjiu "Ibuprofen suspension" has been approved by the State Drug Administration for listing.
CRC Sanjiu's business scope:
The company's business scope at the time of listing is: the development, production and sales of drugs, health care products and medical devices; related technology development, transfer and services; medical and health care services.
In 2001, after the first extraordinary shareholders' meeting in 2001, the company's scope of business was changed to: development, production and sales of pharmaceuticals; related technology development, transfer and services; import of machinery, equipment and raw materials required for production; and export of self-produced products (except for those commodities and technologies whose import and export are restricted or prohibited by the state).
In layman's terms, it is mainly engaged in the research and development, production, sales and related health services of pharmaceutical products. The company's four major pharmaceutical business modules are OTC (over-the-counter), prescription Chinese medicine, decoction-free Chinese medicine, antibiotics and general medicine, supplemented by packaging and printing, medical services and other related businesses.
Reference: Baidu Encyclopedia - China Resources Sanjiu Medicine Co.